---
title: "BeOne Medicines: Q2 2026 revenue up 30% to $1.7B, net income up 151%, driven by strong product sales and margin gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294947927.md"
description: "BeOne Medicines reported Q2 2026 revenue of $1.7B, a 30% year-over-year increase, with net income surging 151% to $237M. Growth was driven by strong sales of BRUKINSA® and TEVIMBRA®, alongside improved margins. The company also expanded its New Jersey facility, achieved positive Phase 3 results, and maintains robust liquidity to support growth and debt obligations."
datetime: "2026-08-05T10:16:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294947927.md)
  - [en](https://longbridge.com/en/news/294947927.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294947927.md)
generator: "portal-rs"
---

# BeOne Medicines: Q2 2026 revenue up 30% to $1.7B, net income up 151%, driven by strong product sales and margin gains

Q2 2026 revenues rose 30% year-over-year to $1.7B, with net income up 151% to $237M, driven by strong BRUKINSA® and TEVIMBRA® sales and improved margins. The company expanded its NJ facility, reported positive Phase 3 results, and maintains strong liquidity to fund growth and meet debt obligations.

Original document: BeOne Medicines Ltd. Class A \[688235\] SEC 10-Q Quarterly Report — Aug. 5 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)

## Related News & Research

- [BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines | ONC Stock News](https://longbridge.com/en/news/297552849.md)
- [How Investors Are Reacting To BeOne Medicines (ONC) First-Line HER2-Positive GEA Immunotherapy Approval](https://longbridge.com/en/news/297146976.md)
- [BeOne Medicines to Present at the Morgan Stanley Annual Global Healthcare Conference | ONC Stock News](https://longbridge.com/en/news/297636674.md)
- [RCS - OptiBiotix Health - H&B launches FORMI™ Product containing SlimBiome®](https://longbridge.com/en/news/297738732.md)
- [BUZZ-Mid-cap drugmakers face limited impact from Trump drug pricing deals, analysts say](https://longbridge.com/en/news/297637201.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**